FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Department of War transports next-generation reactor in nuclear energy milestone

Schumer says Dems will fight voter ID push ‘tooth and nail,’ balks at DHS role in elections

Hillary Clinton clashes with Czech leader over Trump policies at Munich security conference

Woman allegedly steals bus from elementary school parking lot, goes on late night ride

The one sentence in Rubio’s Munich speech that revealed Trump’s red line for Europe

SpaceX Launches New Crew to Space Station After Medical Evacuation

Media Whines About Irish Man Held by ICE, But Here’s Why He’s Really in Trouble

California Exodus Takes a Huge Leap Forward as Citizens Flock to Las Vegas to Avoid New Tax Hike

NBC Issues Apology for Calling Female Olympic Skier ‘She’

US Kill Total on Drug Boats Hits 133 as Strike Takes Out 3 More ‘Narco-Terrorists’ in Caribbean

Trump announces $5 billion pledge in Gaza aid from Board of Peace members

Mobs in India Destroy Christian Homes After Believers Refuse to Renounce Jesus

Rubio defends US operation in Venezuela, calls out reporter for trying to start a fight

Columbia pulls promotion for DHS career expo after faculty claims university is aiding ‘authoritarianism’

UN Head Sends Congratulations to Iran on Anniversary of 1979 Revolution – Weeks After Muslim State Slaughtered Thousands of Its Own Citizens

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”